Table 1.
Demographic data and clinical characteristics of 101 patients with COVID-19.
| Total n = 101 |
Improvement n = 84 |
Progression n = 17 |
t/U/χ2 value | p Value | |
|---|---|---|---|---|---|
| Age (years, mean ± S.D.) | 50.9 ± 20.1 | 46.6 ± 18.3 | 72.4 ± 13.9 | −5.496 | <.001 |
| Gender (male/female) | 44/57 | 34/50 | 10/7 | 1.936 | .164 |
| History of exposure to Hubei province (n, %) | 43 (42.6) | 37 (44.0) | 6 (35.3) | 0.443 | .506 |
| Cluster (n, %) | 78 (77.2) | 63 (75.0) | 15 (88.2) | 0.756 | .385 |
| Duration from first symptoms to diagnosis (d, mean ± S.D.) | 4.8 ± 2.9 | 4.7 ± 2.7 | 5.2 ± 3.6 | −0.600 | .550 |
| Comorbidities (n, %) | 30 (29.7) | 20 (23.8) | 10 (58.8) | 8.301 | .004 |
| Hypertension | 21 (20.8) | 13 (15.5) | 8 (47.1) | 6.753 | .009 |
| Coronary artery disease | 11 (10.9) | 7 (8.3) | 4 (23.5) | 1.981 | .159 |
| Diabetes mellitus | 6 (5.9) | 4 (4.8) | 2 (11.8) | 0.304 | .581 |
| Cerebrovascular | 3 (3.0) | 2 (2.4) | 1 (5.9) | 0.595 | .428 |
| Chronic obstructive pulmonary disease | 4 (4.0) | 2 (2.4) | 2 (11.8) | 3.241 | .131 |
| Malignancy | 5 (5.0) | 4 (4.8) | 1 (5.9) | 0.038 | .846 |
| Symptoms (n, %) | |||||
| Fever | 74 (73.3) | 59 (70.2) | 15 (88.2) | 1.510 | .219 |
| Dry cough | 63 (62.4) | 53 (63.1) | 10 (58.8) | 0.110 | .740 |
| Temperature max (°C, mean ± S.D.) | 38.5 ± 0.6 | 38.5 ± 0.6 | 38.6 ± 0.5 | –0.849 | .399 |
| Respiratory rate (breaths/min, mean ± S.D.) | 20.2 ± 1.8 | 20.0 ± 1.7 | 21.0 ± 2.0 | −2.072 | .041 |
| Heart rate (beats/min, mean ± S.D.) | 85.5 ± 12.8 | 85.6 ± 12.5 | 84.9 ± 14.5 | 0.188 | .851 |
| Mean arterial pressure (mmHg, mean ± S.D.) | 89.7 ± 13.8 | 90.8 ± 10.4 | 84.7 ± 24.4 | 1.678 | .097 |
| Blood oxygen saturation (%, mean ± S.D.) | 96.5 ± 4.0 | 96.8 ± 3.0 | 95.3 ± 7.1 | 1.376 | .172 |
| SOFA (median, IQR) | 1.0 (0.0,1.0) | 0.0 (0.0,1.0) | 3.0 (1.5,4.0) | 6.157 | <.001 |
SOFA: Sequential Organ Failure Assessment.